These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2031394)

  • 1. Tissue concentrations of ofloxacin in necrotic foot lesions of diabetic and non-diabetic patients with peripheral arterial occlusive disease.
    Mueller-Buehl U; Diehm C; Gutzler F; Adam D
    Vasa; 1991; 20(1):17-21. PubMed ID: 2031394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue and serum levofloxacin concentrations in diabetic foot infection patients.
    Oberdorfer K; Swoboda S; Hamann A; Baertsch U; Kusterer K; Born B; Hoppe-Tichy T; Geiss HK; von Baum H
    J Antimicrob Chemother; 2004 Oct; 54(4):836-9. PubMed ID: 15375105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue concentrations of ofloxacin in necrotic lesions in patients with peripheral vascular disease and in diabetics.
    Müller-Bühl U; Diehm C; Gutzler F
    Infection; 1986; 14 Suppl 4():S276-8. PubMed ID: 3469162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue concentrations after a single-dose, orally administered ofloxacin in patients with diabetic foot infections.
    Kuck EM; Bouter KP; Hoekstra JB; Conemans JM; Diepersloot RJ
    Foot Ankle Int; 1998 Jan; 19(1):38-40. PubMed ID: 9462911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream.
    Lipsky BA; Holroyd KJ; Zasloff M
    Clin Infect Dis; 2008 Dec; 47(12):1537-45. PubMed ID: 18990064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparin seems to improve local capillary circulation and healing of chronic foot ulcers in diabetic patients.
    Jörneskog G; Brismar K; Fagrell B
    Vasa; 1993; 22(2):137-42. PubMed ID: 8391741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular and nerve lesions of the diabetic foot--a morphological study.
    Popescu RM; Cotuţiu C; Graur M; Căruntu ID
    Rom J Morphol Embryol; 2010; 51(3):483-8. PubMed ID: 20809024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic therapy for diabetic foot infections: comparison of cephalosporines with chinolones.
    Lobmann R; Ambrosch A; Seewald M; Dietlein M; Zink K; Kullmann KH; Lehnert H
    Diabetes Nutr Metab; 2004 Jun; 17(3):156-62. PubMed ID: 15334793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic foot ulcers.
    Edmonds ME; Foster AV
    BMJ; 2006 Feb; 332(7538):407-10. PubMed ID: 16484268
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibiotic treatment for diabetic foot. Advantages of intravenous regional route as alternative for systemic route].
    Acevedo A; Schoop W; Schnell A; Toledo L
    Rev Med Chil; 1990 Aug; 118(8):881-8. PubMed ID: 2152232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of soluble E-selectin in diabetic patients with severe symptomatic peripheral arterial occlusive disease requiring angioplasty. A possible role in diabetic vascular disease?
    Elhadd TA; Kennedy G; McLaren M; Stonebridge PA; Shaw WJ; Belch JJ
    Int Angiol; 2000 Jun; 19(2):171-5. PubMed ID: 10905802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rehabilitation and treatment of diabetic foot. Vascular problems.
    Lippmann HI
    N Y State J Med; 1979 Feb; 79(2):190-2. PubMed ID: 285346
    [No Abstract]   [Full Text] [Related]  

  • 13. [The diabetic foot].
    Morell B
    Ther Umsch; 1990 Jan; 47(1):55-62. PubMed ID: 2155480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic and therapeutic considerations on the "diabetic foot"].
    Stiegler H; Frey S; Standl E
    Med Klin (Munich); 1988 Mar; 83(7):263-9. PubMed ID: 3288855
    [No Abstract]   [Full Text] [Related]  

  • 15. Foot reconstruction in diabetes mellitus and peripheral vascular insufficiency.
    Searles JM; Colen LB
    Clin Plast Surg; 1991 Jul; 18(3):467-83. PubMed ID: 1889157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soft tissue enhancement on time-resolved peripheral magnetic resonance angiography.
    Zhang HL; Kent KC; Bush HL; Winchester PA; Watts R; Wang Y; Prince MR
    J Magn Reson Imaging; 2004 May; 19(5):590-7. PubMed ID: 15112308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [There is no occluding microangiopathy in diabetic foot].
    Chantelau E; Ibeling M
    Vasa Suppl; 1992; 35():27-8. PubMed ID: 1481050
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of the diabetic foot.
    Hodges D; Kumar VN; Redford JB
    Am Fam Physician; 1986 May; 33(5):189-95. PubMed ID: 3706096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
    Wang J; Zhu YQ; Li MH; Zhao JG; Tan HQ; Wang JB; Liu F; Cheng YS
    J Vasc Interv Radiol; 2011 Jul; 22(7):987-94. PubMed ID: 21570870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infected diabetic foot ulcers.
    Amin NM
    Am Fam Physician; 1988 Feb; 37(2):283-92. PubMed ID: 3278569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.